Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Management of NSAID-related gastrointestinal mucosal injury.

Management of NSAID-related gastrointestinal mucosal injury. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Management of NSAID-related gastrointestinal mucosal injury. Abstract Text:

    a f barrisonA F Barrison,m m wolfeM M Wolfe,

    The three therapeutic goals in patients with NSAID-induced gastroduodenopathy are treatment of dyspeptic symptoms, management of NSAID-related ulcers and their complications, and prophylaxis against recurrent gastrointestinal toxicity. Both H(2)-receptor antagonists and proton pump inhibitors (PPIs) appear to be helpful in relieving the symptoms associated with NSAID use, while treatment of NSAID-induced gastroduodenal ulcers, whether the NSAID is continued or not, is best achieved by the use of PPIs. However, because symptoms do not often predict the presence of gastroduodenal ulcers, the goal of prevention has become paramount in the treatment of patients with an increased likelihood of gastrointestinal toxicity. The best prophylaxis against NSAID-related toxicity is the use of an alternative agent such as salsalate or paracetamol (acetaminophen). However, if an NSAID is to be used, prophylaxis is best accomplished with a PPI or misoprostol, a prostaglandin E1 analogue. The use of misoprostol is limited by its frequent dosing, at least 200 microg three times a day, and its own gastrointestinal side effects. Future therapy will include NSAIDs that maintain their antiinflammatory effects, while possessing superior safety profiles, and include preferential and highly selective COX-2 inhibitors and nitric oxide releasing compounds.

    Management of NSAID-related gastrointestinal mucosal injury. Publishing Authors By Initials

    af barrisonAF Barrison,mm wolfeMM Wolfe,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Management of NSAID-related gastrointestinal mucosal injury. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Inflammopharmacology

    VOLUME: 7

    Page Numbers: 277-86

    Journal Abbreviation:

    ISSN: 0925-4692

    DAY: 19

    MONTH: 07

    YEAR: 1999

    Management of NSAID-related gastrointestinal mucosal injury. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9112626

    Management of NSAID-related gastrointestinal mucosal injury. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Management of NSAID-related gastrointestinal mucosal injury. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Management of NSAID-related gastrointestinal mucosal injury.

    AFFILIATION: Section of Gastwenterology, Boston University School of Medicine and Boston Medical Center, 88 East Newton Street, 02118-2393, Boston, Massachusetts MA, USA, Michael.wolfe@bmc.org.

    Country: Switzerland

    Switzerland Research PublicationSwitzerland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Inflammopharmacology

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Management of NSAID-related gastrointestinal mucosal injury Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News